1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ocugen Inc (OCGN)
  7. News

OCGN

Ocugen News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Ocugen Inc OCGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.28 -12.74% 8.77 19:58:59
Open Price Low Price High Price Close Price Prev Close
10.06 8.56 10.07 8.66 10.05
more quote information »

Recent News

Date Time Source Heading
10/15/202116:03EDGARStatement of Changes in Beneficial Ownership (4)
10/15/202116:02EDGARStatement of Changes in Beneficial Ownership (4)
10/14/202120:10SIUSVolatile ride for Ocugen Inc stock price on Thursday moving..
10/13/202120:08SIUSVolatile ride for Ocugen Inc stock price on Wednesday moving..
10/12/202120:08SIUSHigh volatility in Ocugen Inc stock price on Tuesday which..
10/04/202116:18EDGARCurrent Report Filing (8-k)
9/23/202116:08GLOBEOcugen, Inc. to Participate in Fireside Chat at the Cantor..
9/17/202116:52GLOBEOcugen Inc. Announces Inducement Grants Under Nasdaq Listing..
9/17/202116:02EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202116:57EDGARCurrent Report Filing (8-k)
9/08/202107:32EDGARCurrent Report Filing (8-k)
9/07/202117:22GLOBEOcugen, Inc. to Present at Upcoming Citi and H.C. Wainwright..
9/06/202112:15TRMNIs Ocugen Stock Headed for a Rally?
9/03/202110:13TRMNOcugen Stock Seems Unattractive with Limited Market..
8/20/202116:34GLOBEOcugen Inc. Announces Inducement Grants Under Nasdaq Listing..
8/18/202116:02EDGARStatement of Changes in Beneficial Ownership (4)
8/06/202116:07EDGARProspectus Filed Pursuant to Rule 424(b)(7) (424b7)
8/06/202115:25SEEKOcugen-partnered COVID-19 shot undergoes regulatory review..
8/06/202109:05EDGARQuarterly Report (10-q)
8/06/202108:09SEEKOcugen Q2 R&D expenses surged driven by licensing cost for..
8/06/202107:36SEEKOcugen EPS misses by $0.10
8/06/202107:32GLOBEOcugen Provides Business Update and Second Quarter 2021..
8/05/202104:34TRMNOcugen Q2 Earnings Preview: What’s in Store?
7/30/202117:29EDGARStatement of Changes in Beneficial Ownership (4)
7/30/202108:45GLOBEOcugen to Host Conference Call on Friday, August 6 at 8:30..
7/26/202114:45TRMNOcugen Stock Gets a New Street-High Price Target
7/26/202107:21SEEKBiden officials contemplate the need of COVID-19 booster..
7/23/202113:57SEEKPfizer/BioNTech COVID-19 shot is 39% effective with..
7/21/202116:04EDGARStatement of Changes in Beneficial Ownership (4)
7/20/202107:27EDGARCurrent Report Filing (8-k)
7/16/202116:59GLOBEOcugen Inc. Announces Inducement Grants Under Nasdaq Listing..
7/16/202116:01EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202107:44SEEKOcugen initiates rolling submission to Health Canada for..
7/15/202107:34GLOBEOcugen, Inc. Announces Initiation of Rolling Submission to..
7/12/202115:20SEEKOcugen-partnered COVID-19 shot undergoes WHO review
7/12/202110:42TRMNModerna vs. Ocugen: Which COVID-19 Vaccine Stock Would Be a..
7/09/202116:04EDGARCurrent Report Filing (8-k)
7/02/202119:28SEEKOcugen says partner's vaccine 93.4% effective against severe..
7/02/202117:42GLOBEOcugen’s COVID-19 Vaccine Co-Development Partner, Bharat..
7/02/202116:02EDGARCurrent Report Filing (8-k)
6/29/202111:19SEEKAdjuvant boosts efficacy of Ocugen's COVID vaccine Covaxin
6/25/202117:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/25/202116:19EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202110:23SEEKOcugen partner Bharat Biotech's COVID-19 shot shows 77.8%..
6/21/202115:29SEEKOcugen partner Bharat Biotech submits late-stage trial data..
6/21/202109:12GLOBEOcugen, Inc. Announces Ken Inchausti as Head, Investor..
6/18/202116:12GLOBEOcugen Inc. Announces Inducement Grants Under Nasdaq Listing..
6/17/202117:25EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202109:43SEEKOcugen-partnered COVID-19 vaccine is on track for WHO nod
6/16/202107:30GLOBEOcugen Inc. Set to Join Russell 3000® Index
See more news about this stock »


Your Recent History
NASDAQ
OCGN
Ocugen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.